Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week randomized double-blind placebo-controlled trial of prucalopride in men with chronic constipation
2009-015719-42Phase 3Completed
- Sponsor
- Movetis
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic constipation comparing Prucalopride (Resolor) with Placebo (2 arms). Primary endpoint: Responder rate for spontaneous complete bowel movements. Started May 2010; status: completed.
02
Drugs
prucalopride
03
Conditions
chronic constipation
Beyond the preview
Go deeper on 2009-015719-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015719-42.